about
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouseTreatment of adult growth hormone deficiency: who, why and how? A reviewEchocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?The GH/IGF-1 Axis and Heart Failure.Growth hormone, IGF-I and insulin and their abuse in sport.Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer studyAkt/protein kinase B promotes organ growth in transgenic mice.Are patients with acromegaly at high risk for dysrhythmias?Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.Primary medical therapy for acromegaly.Aerobic capacity and growth hormone deficiency after traumatic brain injury.Clinical manifestations and diagnosis of acromegalyThe insulin-like growth factor system: towards clinical applications.Cardiovascular effects of growth hormone treatment: potential risks and benefits.Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.Etiologic aspects and management of acromegaly.Congestive heart failure in acromegaly: A review of 6 cases.Acromegaly and the cardiovascular system.A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?Insulin signaling pathways and cardiac growth.Growth hormone status predicts left ventricular mass in patients after cure of acromegaly.Now, the Taller Die Earlier: The Curse of Cancer.Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.Promoting physiological hypertrophy in the failing heart.Mouse models of growth hormone action and aging: a proteomic perspectiveDetecting growth hormone misuse in athletes.Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance.Elevated systolic blood pressure in male GH transgenic mice is age dependent.Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia.Detecting growth hormone abuse in athletes.Improvement of cardiac parameters in patients with acromegaly treated with medical therapies.Myths and truths of growth hormone and testosterone therapy in heart failure.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsPrader-Willi Syndrome: A spectrum of anatomical and clinical features.Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly.
P2860
Q24613998-219DC9AF-D489-4354-B1E8-C5F5FC695A60Q28278957-1E7DE029-8883-4BDE-A7C9-1D7FD2567834Q33235036-585A66A7-C6C7-44EF-8CD4-269B28755C0CQ33569163-A795FB41-0A62-4A79-ABAB-89C36443CE5CQ33654009-F1DA1CF5-7DEF-4CC8-BE4B-B6CF08AF88A6Q34010760-A7B86558-1424-4C19-B5F7-7B2AFF901CB1Q34267323-12D0ADFA-9F66-42DB-B482-13CADE0404F3Q34276940-08786771-8FF7-445D-94A2-1A26B5503B8FQ34394095-59E0DFEB-DECB-4C1C-809D-07E6A0C9FDD3Q34677468-54895EA5-996A-4D32-8E7D-C7EE8C84C6DEQ35086868-443F8EBF-0011-4CE6-ADC7-A40D90BB83DAQ35544583-37B79E61-3C57-43F7-ADD0-BEF4980334D3Q35810485-7D9FE64E-A011-4A45-8004-DCA329567035Q35819252-9D7ACBCA-1DBB-45A6-A901-4E92EE97AC1FQ35946594-6ABE6C1E-8C18-4CB4-99D4-B20B9FF0828BQ36350066-0A42183F-15A3-4CB7-98E6-B274FBE42F22Q36380875-F6298E0A-235F-4704-BACE-1D6B5085ACF7Q36436541-DF3DC293-4A2D-41A6-9217-8148F07A6D7CQ36626490-3CD1EF07-9A04-457F-AF18-0B6310FE7508Q36707004-FEFC3999-B100-4104-8363-5EDF42D92D88Q36742620-A18E333F-53A9-49C6-B549-671BAB5450C6Q36896880-BCA30012-20B0-425E-A548-180B8335367BQ36954884-3C2C663C-162F-4DFF-B0F2-8ABA304270D8Q37091119-8D621550-5724-4DC5-B92B-69FECA5A2248Q37097122-13DF2F4D-5E4C-4D95-B761-EBD17B26EEE4Q37130681-8CDDAC13-C466-4A1E-B35C-ECA42166D5C2Q37314582-3E4F5DAD-0104-4137-B935-454615477AEBQ37322413-756FE02D-45E5-43A8-AAEC-4066B4B9EC68Q37410737-0C87D4E1-4278-4123-A6AD-285F44DB0C36Q37594091-CAF93670-E4B1-403C-825F-5ECE75CB1C0EQ37858644-E6DD3D20-7ABC-486C-81A7-38574FA4470EQ37876785-C97CA5F2-8C5D-426E-BD26-4EB7AB504050Q37895525-560222C2-8FD1-4180-87FA-80B5ADBE94F8Q37895679-D608820C-7F48-478C-AFD7-EDAEBFA4B883Q38166623-3F412E7D-EB28-4F66-8947-20208FDFF045Q38691540-10313820-56F1-4604-9EDE-877DF825A055Q38729143-77E43F68-8E3F-4000-882C-6D957CD51D59Q39064562-02D99EF9-7C1E-493B-90DB-697B0780932FQ39146196-A42E74CB-A925-45FC-954F-3612482FE4E2Q39687911-5B9628FB-4506-4341-85A4-609A67594825
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Growth hormone and the heart.
@ast
Growth hormone and the heart.
@en
type
label
Growth hormone and the heart.
@ast
Growth hormone and the heart.
@en
prefLabel
Growth hormone and the heart.
@ast
Growth hormone and the heart.
@en
P2093
P2860
P1476
Growth hormone and the heart.
@en
P2093
Di Somma C
Lombardi G
Marzullo P
P2860
P304
P356
10.1046/J.1365-2265.2001.01218.X
P577
2001-02-01T00:00:00Z